Galen Growth commends each of the top 25 pharma and biotech companies for securing a position in the 2023 Digital Health Innovation Index.
The Pharmaceutical Digital Health Innovation Index assesses the Digital Health portfolios of pharmaceutical and biotech firms, with a focus on the strength of portfolio ventures as well as the alignment of portfolio ventures with strategic objectives. The 2023 edition of the Index captures the current imperative for companies to focus on improving operational efficiency using digital tools. To secure a place in the top 25, companies must have a global reach and at least 14 publicly announced partnerships with private Digital Health ventures.
Insights from the Pharmaceutical Digital Health Innovation Index:
This report is the 3rd edition of our Pharmaceutical Digital Health Innovation Index. You can download our last years comprehensive report, capturing insights from the 2022 edition on our Research page.
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.
Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com
|GALEN GROWTH DIGITAL HEALTH INNOVATION INDEX: 1 page, 1 chart
|TOP 10 STRATEGIC FIT: 1 page, 1 table
|TOP 10 VENTURE PORTFOLIO SCORE: 1 page, 1 table
|PHARMA PROFILES: 5 pages, 5 tables
|METHODOLOGY: 3 pages
|FOCUS ON RESEARCH AND PATIENT ENGAGEMENT: 1 page, 2 tables
|CRITICAL SUCCESS FACTORS: 1 page
|DEEP DIVE PHARMACEUTICAL PARTNERSHIPS: 8 pages, 2 tables, 8 charts
|ABOUT GALEN GROWTH